Page 1373 - Problem-Based Feline Medicine
P. 1373
20 – THE CAT WITH ENLARGED LYMPH NODES 13651365
DRUG INDEX
15–30 min; 25 5–7 days, then Continued
5 min infused over as needed 24, max 5 mg DOCA released for dose taper with mineralocorticoids 15 minutes before doxirubicin
over 6–12 24 repeat 12–24 12–24 12–24 days then, 8–12, then 8–12 6–8 12–24 12 for then 8–24
IN, conjunctival conjunctivally IN, conjunctival conjunctivally IM = 1mg/day
IV, IM IV PO PO PO IV IV, SC IV, SC, PO IV, PO, IM IV(slowly) PO SC, PO SC, IV IV PO IV
9 kg to 4.5 kg give 0.35 ml 0.3 : μ/kg (diluted in 50 ml saline) (ratio of 10–20:1 Dexrazoxane:
10 mg/kg 50 mg/kg 3–12 mg/kg selegiline see 1 capsule per 2–4 drops 0.1 mg 1–2 drops 0.2–0.4 mg/kg 25 mg 2 mg/kg CNS trauma 1 mg/kg 0.1 mg/kg 0.25 mg/kg 4–6 mg/kg 0.25–1.25 mg/kg 0.10–0.15 mg/kg 0.1–0.5 mg/kg 1 mg/kg 0.25–1.0 mg/cat 25 mg/kg doxorubicin)
Repertusion injuries Innappropriate ADH secretion Hyperadrenocorticism, Cognitive dysfunction Skin disorders Skin disorders Central diabetes insipidus Hypoadrenocorticism Hypoadrenocorticism Cerebral edema, spinal cord trauma, fibrocartilaginous disease, other disk Hydrocephalus Shock, anaphylaxis Immune-mediated disease Adrenocortico collapse Feline bronchial asthma doxorubicin Iron chelat
Demeclocycline Deprenyl Derm caps Derm caps (liquid) Desmopressin acetate Desoxycorticosterone acetate Desoxycorticosterone pivalate Dexamethasone Dexrazoxane
